PGEN: Precigen, Inc. Company Short-Term Debt

Symbol and logo of brand Precigen, Inc. (PGEN)

Precigen, Inc. (PGEN) is preparing to launch its advanced platforms as it finalizes tests for its papillomatosis drug. The company is investing massive resources into R&D, developing the UltraCAR-T system for rapid cell production within clinics. This price chart, serving as confirmation of the market valuation, reflects a trend where the metric stands at 0.00. Business development relies on partnerships with oncology centers to collaboratively identify treatments for severe pathologies.

PGEN (Precigen Inc) Company Short-Term Debts history from 07/04/2022 to 10/30/2026
Manufactured products of Precigen, Inc.

This indicator reflects the density of borrowed capital and the current volatility of business liabilities. In fundamental analysis, this metric captures the volume of short-term loans due for repayment within the coming year. Short-term debt load dynamics allow for an assessment of liquidity and the speed of debt service. For Precigen, Inc. (PGEN), this is critical when financing energy-saving systems and the eco-friendly disposal of biomaterials. Debt control confirms the biotechnology company's ability to maintain strict ESG standards.

Competitor analysis

ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts immunovant.com|Company Current Liabilities KNSA (Kiniksa)|GRFS (Grifols SA) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ADPT (Adaptive Biotechnologies Corp)|Short-Term Debt Volume Celldex Corp (CLDX)|AUPH - Company Short-Term Debt|biocryst.com (BCRX) - Company Current Liabilities|Vera Therapeutics (VERA) - Company Short-Term Debt|Company Current Liabilities Dianthus Therapeutics Inc|Company Current Liabilities PHVS|Company Short-Term Debts abcellera.com|Company Short-Term Debt Tourmaline Bio, Inc. (TRML)|pharming.com - Company Short-Term Indebtedness|Company Short-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Short-Term Debt|ZBIO - Company Short-Term Debt|Current Liabilities IMNM|Gossamer Bio, Inc. (GOSS) - Company Short-Term Debt|kalvista.com - Company Short-Term Loans and Borrowings|SEPN (Septerna) - Company Short-Term Debts|Short-Term Debt Pieris Pharma PVLA|Company Short-Term Debts SVRA|Company Current Liabilities Rigel Corp RIGL|Company Short-Term Debts ANAB (AnaptysBio, Inc.)|Short-Term Debt Volume astriatx.com (ATXS)|enGene - Company Short-Term Debts|Short-Term Indebtedness rapt.com (RAPT)|JBIO: Company Short-Term Debts|Short-Term Debt Aclaris Therapeutics, Inc (ACRS)|Company Short-Term Debt Kyverna Therapeutics|Company Short-Term Indebtedness TLSA (tizianalifesciences.com)|Company Current Liabilities CABA (Cabaletta Bio)|VTYX (Ventyx Biosciences Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debts THTX (Theratechnologies Inc)|Short-Term Debt Volume Avalo Therapeutics Inc (AVTX)|ELDN - Company Short-Term Debt|AGEN (agenusbio.com) - Company Short-Term Indebtedness|CLYM: Company Short-Term Debts|Company Current Liabilities zurabio.com|Company Current Liabilities ATYR|Adagene Corp (ADAG) - Short-Term Debt Volume|Company Short-Term Debt ImageneBio Inc (IMA)|STTK: Current Liabilities|Company Short-Term Debts EQ (Equillium)|Short-Term Indebtedness Connect Biopharma Holdings|Immunic Inc - Company Short-Term Debts|Short-Term Debt Atara Biotherapeutics|inflarx.de (IFRX) - Company Short-Term Debt|Company Short-Term Indebtedness XFOR|Company Short-Term Debt Adicet Bio Inc.|Celularity Corp - Current Liabilities|Company Short-Term Debts INMB|BRNS (Barinthus Biotherapeutics Corp) - Company Short-Term Loans and Borrowings|Company Short-Term Debts KZR (Kezar Life Sciences)|Company Short-Term Debts sabbiotherapeutics.com SABS|AKTX - Company Short-Term Debt|Company Short-Term Loans and Borrowings ENLV (Enlivex Therapeutics)|q32bio.com (QTTB) - Company Short-Term Debt|Company Current Liabilities GeoVax Corp|EDSA (Edesa Biotech, Inc.) - Company Short-Term Debts|Company Short-Term Debts ibioinc.com|Company Current Liabilities CARM (Carisma Therapeutics)|XTLB (XTL Biopharmaceuticals Ltd) - Company Short-Term Loans and Borrowings|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Short-Term Debt Volume HCW Biologics, Inc. (HCWB)|APVO - Company Short-Term Debt|aimimmuno.com (AIM) - Company Current Liabilities|aditxt.com (ADTX) - Company Short-Term Debt|Company Current Liabilities GRI Bio Inc|Company Current Liabilities XRTX|Company Short-Term Debts Vyome Therapeutics|Company Short-Term Debt Revelation Biosciences (REVB)|indaptusrx.com - Company Short-Term Indebtedness|Company Short-Term Debts SCNI (Scinai Immunotherapeutics Ltd.)|CalciMedica Inc (CALI) - Short-Term Debt|AFMD - Company Short-Term Debt|Current Liabilities ALLK|hookipapharma.com (HOOK) - Company Short-Term Debt|IGM Biosciences - Company Short-Term Loans and Borrowings|ITOS (iTeos Therapeutics, Inc.) - Company Short-Term Debts|Short-Term Debt Ocean Biomedical Inc OCEA|Company Short-Term Debts TCBP|Company Current Liabilities Third Harmonic Bio Inc THRD